Emerging drugs for chemotherapy-induced emesis

Author： Navari Rudolph M   Province Paula S  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.11, Iss.1, 2006-03, pp. : 137-151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Early intervention prevents delayed, chemotherapy-induced emesis

By  

Inpharma, Vol. 1, Iss. 1240, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Anti-Emetics for Cancer Chemotherapy-Induced Emesis: Potential of Alternative Delivery Systems

By Kraut L.   Fauser A.A.  

Drugs, Vol. 61, Iss. 11, 2001-01 ,pp. : 1553-1562

Adis International

Access to resources Recommend Favorite

Stratified Administration of Serotonin 5-HT Receptor Antagonists (Setrons) for Chemotherapy-Induced Emesis: Economic Implications

By Sanchez L.A.  

PharmacoEconomics, Vol. 18, Iss. 6, 2000-12 ,pp. : 533-556

Adis International

Access to resources Recommend Favorite

Palonosetron: a unique 5-HT3-receptor antagonist for the prevention of chemotherapy-induced emesis

By Grunberg Steven M   Koeller James M  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2297-2303

Informa Healthcare

Access to resources Recommend Favorite

New drugs for chemotherapy-induced nausea and vomiting: focus on palonosetron

By Tonini Giuseppe   Vincenzi Bruno   Santini Daniele  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 1, 2005-06 ,pp. : 143-149

Informa Healthcare

Access to resources Recommend Favorite